August 1st, 2014
The reliability of current guidelines regarding perioperative evaluation and treatment of people undergoing noncardiac surgery has been seriously questioned because of a scandal discrediting Don Poldermans, a Dutch researcher widely published in the field. To address the current uncertainty, U.S. and European medical societies today released updated versions of these guidelines. The European guideline can be […]
April 24th, 2014
This week’s topics include trials of aspirin and clonidine in patients undergoing noncardiac surgery, changes in diabetes-related complications in the U.S., and more.
April 23rd, 2013
The use of perioperative beta-blockade for noncardiac surgery has been declining as a result of the controversial POISE study, which turned up evidence for harm associated with extended-release metoprolol in this setting. Now a large new observational study published in JAMA offers a contrary perspective by suggesting that perioperative beta-blockade may be beneficial in low- […]
June 5th, 2012
A new study in JAMA finds that postoperative troponin T (TnT) tests can independently improve 30-day-mortality risk assessment among patients who have undergone noncardiac surgery. The VISION (Vascular Events in Noncardiac Surgery Patients Cohort Evaluation) study investigators evaluated the prognostic power of postoperative fourth-generation TnT testing in 15,133 patients. Overall mortality at 30 days was 1.9%. Some 11.6% of patients […]